CVS Health ($CVS) Executive Vice President and Group President Prem Shah purchased approximately $2 million in company stock on November 6, its first reported open-market insider purchase since June 2025. The transaction follows CVS’s announcement that Shah will lead CVS Pharmacy after a planned separation.
- Shah bought 23,855 shares at $83.895 each, increasing his direct holdings approximately 36.9% to 88,516 shares.
- Director Guy Sansone’s June 5, 2025 purchase of 1,570 shares was the last indsider purchase at CVS.
- CVS announced November 4 that it plans to separate its retail pharmacy business from its insurance, pharmacy services and care-delivery operations. Completion is expected in the first half of 2028, subject to customary conditions.
- Third-quarter revenue increased 5.4% to $108.4 billion, with adjusted earnings of $2.09 per share. CVS raised full-year adjusted earnings guidance to at least $8.20.
- Separately, CVS’s reported 13F portfolio value increased approximately 91% quarter over quarter to an est. $429.4 million at the end of Q3. Total positions expanded from 21 to 36, including new healthcare, technology, energy and gold funds.
Relevant Companies
- CVS Health ($CVS): Shah increased his ownership ahead of the planned separation.
Editor’s Note: This is a developing story. This article may be updated as more details become available.
